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SEMEN QUALITY AND CHEMICAL OXIDATIVE STRESS; QUANTIFICATION 
AND REMEDIATION  
SALEEM A. BANI-HANI 
ABSTRACT 
The necessary multi-step process to prepare human semen for assisted 
reproduction (AR) such as in vitro fertilization (IVF) is known to induce oxidative stress 
in human spermatozoa and subsequent damage to the integrity of their cell components 
and, thus, to their function. Literature reports have viewed this as a potential link with the 
high frequency of birth defects among the IVF babies. In this work, we studied the effect 
of incubation and centrifugation on human sperm quality using established AR protocols. 
We found that in vitro incubation and centrifugation (20 min at 220g) of sperm generally 
degrade sperm quality in terms of motility and DNA oxidation. The total antioxidant 
capacity of the semen significantly decreased upon raising the centrifugation force from 
220g to 400g. We then studied the efficacy of supplements such as L-carnitine (LC) on 
remediating the oxidative stress. We found that supplementation with LC counteracts the 
overall damage of quality brought by the multi-step method of sperm processing. We 
determined the LC concentration range (0.1-1.0 mg/mL) with optimum oxidative stress 
remediation and which enhances qualities such as motility. Among the various oxidative 
stress species, we particularly focused on nitric oxide as a species with known dual 
functional and cytotoxic properties. We have demonstrated a method to monitor its 
dynamic concentrations in spermatozoa. The method enabled us to establish a link 
between motility and nitric oxide levels in spermatozoa. The method also allowed us to 
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establish that the LC-induced enhancement of human sperm motility is also accompanied 
with a simultaneous increase in NO production.  
 vii 
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CHAPTER I 
 
INTRODCUTION AND OVERVIEW 
 
 
1.1 Assisted reproductive technologies 
Assisted reproductive technologies (ART) are the artificial techniques used to 
facilitate the pregnancy for couples who are trying to conceive without success. The most 
common ones are In vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI) and 
intrauterine insemination (IUI) [1; 2].   
In IVF, the fertilization process, i.e. sperm and egg fusion, occurs outside the 
female’s body in the Petri dish. The ultimate goal of this procedure is to increase the 
chance of fertilization that is not achieved through the normal intercourse. In IVF, the 
oocyte production is first induced using hormonal therapy. After ovulation, the eggs are 
retrieved from the female’s ovary; in the meantime, sperm, fresh or cryopreserved, from
 2 
 
the male are prepared and added to the female’s oocytes. The fertilized egg (gamete) is 
then incubated at 37ºC in the dark in highly sterilized conditions until the embryo is 
formed. After that, the embryo is transferred and placed in the center of female’s uterus 
in order to achieve the pregnancy. In fact, several embryos are usually prepared and 
placed into the uterus so as to increase the success rate of the process.  
The main primary steps of ovarian induction, oocyte retrieval technique, sperm 
preparations and embryo culture methods in IVF cycles are similar to those in ICSI 
cycles. Unlike IVF, in ICSI, the spermatozoa is selected based on certain criteria; 
spermatozoa of good motility and morphology is selected and injected artificially by the 
embryologist using a mico-needle inside the oocyte [3; 4] (figure 1-1). ICSI technique is 
mainly used to solve problems of severe male factor infertility as well as other problems 
that lead to failure of natural fertilization [3; 5].   
In IUI, highly-motile washed sperm are injected into the female’s uterus using a 
special plastic catheter [6]. The rationale of this method is to increase the number of 
highly-motile sperm at the site of fertilization, and hence increasing the probability of 
fertilization. IUI is used in cases where the sperm are unable, or barely able, to reach the 
oocyte in the female’s body spontaneously. Such conditions are sexual dysfunction, 
asthenospermia (low sperm motility), and antagonistic cervical conditions such as 
increased cervical mucus thickness [6; 7; 8; 9].       
 
 3 
 
 
 
Figure 1-1: ICSI procedure. (A) the selected spermatozoa is immobilized and aspirated 
into a microinjection pipette;(B) the oocyte is secured using a holding pipette and a 
microinjection pipette; (C) the trapped spermatozoa is injected gently into the oocyte. 
(Adapted from M.C.Schiewe I, 1996). 
 
 
 
 4 
 
1.2 Human semen processing for ART  
Whether the sperm is fresh or cryopreserved, semen processing is routinely 
performed in all ART. Contemporary processing techniques of sperm preparation for 
ART require prolonged incubation as well as repeated centrifugation of human semen to 
separate sperm from the seminal plasma at speeds of 200-400g for 10 to 20 minutes. The 
processing of sperm should be gentle to allow the recovery of highly motile spermatozoa 
that are morphologically and functionally normal. Nevertheless, reports show that sperm 
centrifugation may generate low sperm quality, likely, by affecting the DNA integrity of 
sperm [10; 11]. New findings suggest that some birth defects occur more often among 
infants conceived with ART [12]. 
1.3 Reactive oxygen species and oxidative stress  
Free radicals are highly reactive molecules or atoms that contain an unpaired 
electron. Among free radicals in biological systems, reactive oxygen species (ROS) are 
the most important due to their high reactivity in the body (figure 1-2). They are 
associated with the onset of a variety of diseases including cancer, arteriosclerosis, 
cardiovascular disease, infertility, and a host of inflammatory diseases [13]. The most 
important ROS in the human body are superoxide radical (O2
–
·), hydroxyl radical (·OH), 
Nitric oxide (NO), and the non-radical derivative hydrogen peroxide (H2O2) [14]. 
Endogenous entities such as mitochondria [15], peroxisomes, lipoxygenases, NADPH 
oxidase and cytochrome P450 as well as exogenous factors such as ultraviolet light, 
ionizing radiation, chemotherapeutics inflammatory cytokines, and environmental toxins 
are considered as to be among major factors that generate ROS in living cells [16].  
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Figure 1-2: Lewis structure of dioxygen and some reactive oxygen species (ROS).  
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In live cells, the disturbance in the balance between oxidants and antioxidants in 
the favor of the former is termed as oxidative stress. Increased levels of free radicals such 
as O2
–
·, NO and ·OH are capable of damaging DNA as well as the proteins and lipids, 
and ultimately leads to cell injury or cell death (Figure 1-3) [17; 18]. The mechanisms of 
the products formed by oxidative stress vary depending on the nature of free radical and 
its molecular target [18]. Some of oxidative products could be a rigid sign of oxidative 
stress and can be used as markers to assess the extent of the oxidative damage. For 
example, 8-oxo-guanine (8-oxodeoxyguanosine) serves as a sensitive marker to estimate 
the level of DNA damage caused by hydroxyl radicalS [19; 20].  
 
1.4 Antioxidants role in human body  
Antioxidants are substances capable of counteracting the free radical oxidative 
damage in body tissues [17]. They could be dietary, such as -tocopherol (vitamin E) and 
ascorbic acid (vitamin C), or synthesized in the body like glutathione [21]. Antioxidants 
have attracted a great deal of attention for the defense they provide against oxidative 
stress [17]. Several studies showed that supplementation of dietary antioxidants such as 
vitamin E and β-carotene is associated with decreasing the risk of many diseases, such as 
heart diseases [22], cancer [23], Alzheimer’s disease, Parkinson’s disease, and 
amyotrophic lateral sclerosis [24; 25; 26]. 
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1.5 Oxidative stress, antioxidants and human sperm quality in assisted reproduction  
Oxidative stress in human spermatozoa may be due to the lack of molecular defense 
mechanisms and increased sources of ROS [27]. Various studies have reported the role of 
oxidative stress in male infertility pathogenesis [28; 29]. Male infertility problems such 
as asthenozospermia and necrozoospermia may due to oxidative stress [27]. Similar to 
the effect of oxidative stress in other types of cell types, both sperm DNA and sperm 
membrane are affected negatively by oxidative stress (Figure 1-3), which consequently 
decreases the change of reproductive outcomes [27]. 
Sperm preparation for assisted reproductive technologies includes various routine 
steps such as incubation, cryopreservation and centrifugation. This induces oxidative 
stress and subsequently affects negatively the quality of sperm. The use of antioxidants to 
improve human sperm quality during processing for ART have been used extensively in 
the last 2 decades. Although there is a great evidence supporting the use of antioxidants 
to improve sperm quality in assisted reproduction [30; 31; 32; 33], optimal concentrations 
and the correct combination of the antioxidants should be cautiously standardized. In 
chapter III we will report on the efficacy of L-carnitine, a potent antioxidant, in 
improving sperm quality during centrifugation and prolonged incubation in vitro for use 
in ART protocols.   
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Figure 1-3: semen processing for ART such as IVF induces ROS against sperm.  
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1.6 Flow cytometry: an overview 
In our experimental work, we intensively used flow cytometry to explore the 
effect of various factors affecting human spermatozoa in assisted reproduction. In 
addition, we standardized a method to detect the intracellular nitric oxide in human 
spermatozoa using flow cytometry. Therefore, there is a need to provide an overview of 
the main principles and fundamentals of this technique.        
Flow cytometry is a technique for the analysis of various parameters of individual 
cells. It is used in a wide range of applications to measure different cell characteristics 
such as size, fluorescence, shape, viability, intracellular pH, intracellular redox state, and 
others. Besides, a variety of cell components can be determined using flow cytometry 
such as DNA, RNA, protein, Lipid, antigens, surface receptors, calcium and others. The 
flow cytometer achieves this analysis via passing a representative population of cells 
from the sample through a laser beam and capturing the emerged light from each 
individual cell as it passes through [34]. 
The main components of the flow cytometer are: (a) the fluidics (hydrodynamic 
focusing system). This system allows the chosen cell population to pass the laser beam 
one at a time (Figure 1-4). The intersection point between the laser beam and the cell is 
termed as interrogation point. (b) The laser, which represent the light source in the flow 
cytometer. (c) The optics, their main function is to gather the light from the cells after 
crossing the laser beam. (d) The detectors; they receive the accumulated light from the 
optics. (e) The computer system and other electronics, which convert the detector’s 
signals into digital data and analyzes the data [34; 35; 36].     
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At interrogation point, when the cell crosses the laser beam, two types of light 
scatter are formed: (a) forward scatter (FSC), which is the light, scattered in the forward 
direction, and (b) side scatter (SSC), which is the light scattered on the sides (Figure 1-4). 
In general, the forward scatter provides information about the size of the cell, whereas the 
side scatter provides information about characteristics within the cell such as granularity 
inside the cytoplasm, shape of nucleus, and membrane irregularity [37; 38; 39].  
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Figure 1-4: a representative scheme of flow cytometer system (see the text for details). 
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 FSC is proportional to the size of cells that are passing the laser [38]. The bigger 
the cell size, the higher the FSC intensity. The detector converts the forward scattered 
light into a voltage pulse. Hence, the size of cell is finally proportional to the magnitude 
of the voltage pulse. The plot of cell count versus FSC is called forward scatter histogram 
(FSCH) (Figure 1-5). In this histogram, the larger cells appear on the right.  
SSC is the light scattered at higher angles compared to the FSC. The main 
determinants of the angles of the scattered light are the structural complexity of the cell, 
as we have mentioned above. A separate detector in the flow cytometer, other than one 
used for FSC, is used to gather the side scattered light; it is usually placed 90° from the 
laser beam path. The plot of cell count versus SCC is also a one-dimensional histogram 
named side scatter histogram (SSCH) (Figure 1-6). It is similar to the FSCH, but it 
provides information about the cells characteristics under investigation.  
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Figure 1-5: Flow cytometry forward scatter-histogram. Cells are sorted according to their 
sizes 
 
 
Figure 1-6: Flow cytometry side scatter-histogram. Cells are sorted according to their 
complexity fluorescence.  
 
 
Figure 1-7: Flow cytometry fluorescence-histogram. 
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Fluorescence is another phenomenon used as handle to quantify a given property 
within cells. At the fundamental levels, it is a term used to describe light emission, 
mainly visible, from an excited fluorophore. The emission occurs when the fluorophore 
returns to its ground state from an excited state. Figure 1-8 is the Jablonski diagram 
(energy state diagram) of a fluorophore excitation and emission. The emitted light from a 
fluorophore occurs at a higher wavelength. For example, the fluorophore fluorescein 
isothiocyanate (FITC) that we used in this work to detect DNA oxidation can be excited 
with the blue light at 494 nm; while it emits the green light at 518 nm.    
Fluorescence emitted from cells labeled with a fluorophore travels in the same 
path in the flow cytometer as the side scatter light. This path contains a number of light 
filters so as to deliver each range of wavelengths to the proper detector. Same as data 
collection in the cases of FSC and SSC, the light directed to the detector is translated into 
a voltage pulse. The more the light emitted from the cell, the higher the voltage pulse 
translated. The plot of intensity of fluorescence versus cell count is termed as flow 
cytometry fluorescence-histogram, which provides information about cell fluorescence 
that is increasing in the right direction (Figure 1-7).   
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Figure 1-8: Jablonski diagram (Energy state diagram) - fluorophore excitation and 
emission. The fluorophore emission usually occurs at a lower wavelength; for example, 
the fluorophore Fluorescein isothiocyanate (FITC) can be excited at 494 nm, while it 
emits the light at 518 nm.    
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Forward scatter histogram is not necessarily showing the complexity of the cells. 
In other words, the peak population that appears in the FSCH could be a representative of 
multiple population. This problem can be resolved by looking at the data in the second 
dimension using a two-dimensional scatter plot or dot plot (Figure 1-9). In this plot (SSC 
versus FSC), we can look at both cellular parameters together: cell size and cell 
complexity.      
Another important problem in flow cytometry is to analyze only the cells of 
interest. In many cases, cell fragments such as, small immature cells and debris, and 
sometimes bigger cells that are not of interest interfere with the measurement. This 
problem can be solved by establishing a threshold, or discriminator before start analyzing 
the cells. This will exclude interferences for compounds that are not of interest.    
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Figure 1-9: flow cytometry Scatter or dot plot. Cells are analyzed for both complexity 
and size. 
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CHAPTER II 
 
SEMEN QUALITY DURING PREPARATION FOR ASSITED REPRODUCTIVE 
TECHNOLIGIES 
 
2.1 Introduction  
Sperm centrifugation, required for sperm washing, is a routine technique during 
sperm processing for assisted reproduction technologies (ART). Reports from our 
laboratory showed a significant increase in reactive oxygen species (ROS) during sperm 
centrifugation. Studies have shown a decrease in fertilizing capacity of human 
spermatozoa, and an increase in the birth defects among the ART babies compared to the 
normal babies. Here, we examine the effect of centrifugation on total antioxidant capacity 
(TAC) of human semen on one hand, and on DNA oxidation, motility, and viability of 
sperm, on the other. We measured sperm motility, viability TAC and sperm DNA 
oxidative damage after centrifugation of semen samples for 20 min at 220g. DNA 
oxidative damage in sperm was measured using both electrochemical and flow cytometry 
methods. Centrifugation significantly decreased sperm motility. The total antioxidant 
 24 
 
capacity of the semen significantly decreased upon raising the centrifugation force from 
220g to 400g. Concomitantly, the baseline of DNA oxidative damage in sperm increased 
after centrifugation. Together, sperm centrifugation during processing for ART increases 
oxidative stress in sperm, which negatively affects their quality. This could be one factor 
behind the negative reproductive outcomes. 
 
2.2 Research methods and experimental design  
In this chapter we aimed to examine the effect of centrifugation on sperm quality 
according to the assisted reproduction protocols. We used DNA oxidation, motility and 
viability of sperm, as well as total antioxidant capacity (TAC) of semen as measurement 
criteria to study this effect. The oxidative DNA damage in sperm was evaluated using 
both electrochemical and flow cytometry techniques. We also adapted an assay based on 
cupric reducing antioxidant capacity (CUPRAC) to measure the TAC in human semen 
[1].   
2.2.1 Sample collection 
       The present study was approved by the institutional review board of Cleveland Clinic 
Hospital. Forty normospermic men were chosen and analyzed on the basis of normal 
semen analysis according to the World Health Organization (WHO, 1999) guidelines [2]. 
The effect of centrifugation on TAC of semen as well as DNA oxidation, motility and 
viability of sperm were examined. Samples were centrifuged at 1600 rpm (220g) for 20 
minutes similar to sperm preparation protocols used in ART.  Samples were collected by 
masturbation after a minimum of 48 to 72 hours of sexual abstinence. Following 
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liquefaction at 37 ºC for 20 minutes, semen specimens were evaluated for volume, sperm 
concentration, total cell count, motility, and morphology. 
2.2.2 Effect of centrifugation on sperm motility and viability  
 Two equal aliquots (5 X 10
6 
sperm) were prepared from each of the sixteen 
normospermic semen samples, and mixed with human tubal fluid (HTF; 1:1 vol. / vol.). 
The first aliquot was centrifuged at 1600 rpm at 25 ºC; while the second aliquot (control) 
was just incubated at the same temperature. Sperm motility and viability was measured 
after 20 min. A total amount of 5µL of the sample was used for evaluation of 
concentration and motility using a micro-cell slide chamber (Figure 2-1) (Conception 
Technologies, San Diego, CA).  
Sperm viability was measured by the Eosin-Nigrosin staining method (Figure 2-
2). To one drop of liquefied semen placed on a Boerner slide, two drops of 1% aqueous 
Eosin was added and mixed with a wooden stirrer for 15 seconds. Then, three drops of 
10% aqueous Nigrosin were added and mixed well. Thin smear was made by pipetting 
10µL onto a slide and allowed to air dry. Slides were mounted with a coverslip using 
Accu-mount media. Measurements were performed on two hundred sperm counted on 
each slide in duplicate sets using an X100 objective. Percentage of viable (unstained) 
sperm and non-viable (stained) were calculated.   
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Figure 2-1: Sperm motility assessment.  5µL of semen sample is used to assess motility 
using a disposable micro-cell slide chamber (an example is shown in the figure). 
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Figure 2-2: Sperm viability measurement using the Eosin-Nigrosin test. Stained sperm is 
considered viable, while unstained one (white) is considered non-viable.   
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2.2.3 Effect of centrifugation on total antioxidant capacity  
Semen samples (n=10) from healthy donors, were divided into two aliquots; each 
contained 0.5 mL of semen. We centrifuged the first aliquot at 220g for 20 min at 25 ºC, 
while the second aliquot (control) was incubated for 20 min at the same temperature. 
Semen samples (n=10), in another experimental set, were subjected to the same treatment 
as described above, but centrifuged at a higher centrifugal force (400g). 
We adapted the cupric reducing antioxidant capacity (CUPRAC) method to 
measure the total antioxidant capacity in semen [1]. Briefly, 1 mL of working solution 
(CuCl2 solution; 0.02 M), neocuproine alcoholic solution (0.0075 M) and 1-mL 
ammonium acetate (NH4Ac) buffer solution (1:1:1 vol./vol./vol.) was mixed in a 
centrifugation tube with 12.5 μL of seminal plasma. All reaction tubes were centrifuged 3 
min at 4000 rpm, and the entire supernatant was collected for use in absorbance 
measurements.  The absorbance of the colored complex formed was measured against the 
reagent blank at 450 nm after 30 min incubation at room temperature (Figure 2-3) [3].  
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Figure 2-3: Cupric ion reducing antioxidant capacity (CUPRAC) principle. The colored 
complex (Neocuproine-Cu
+1
) is formed after reducing cupric ion by semen antioxidants. 
The intensity of the color is proportional to the total antioxidant activity in semen.   
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2.2.4 Measurement of DNA oxidation by Flow cytometry  
Semen samples (n=5) from healthy donors were divided into 2 aliquots (5 X 10
6
 
sperm) and centrifuged at 1600 rpm for 20 min. at 25ºC. Controls were incubated for 20 
min. at 25ºC.   Oxidative damage to DNA was evaluated using the flow cytometric 
OxiDNA assay kit (Calbiochem, San Diego). The assay is based on  fluorescent protein 
that binds to oxidized moieties on DNA (Figure 2-4). Briefly, both treated sperm samples 
and controls were washed in phosphate saline buffer, resuspended in 1% 
paraformaldehyde at a concentration of 2-4 x 10
6
 cell/ mL, and placed on ice for 15 to 30 
minutes. Sperm were again washed and resuspended in 70% ice-cold ethanol by 
centrifugation at 300g for 5 minutes as per kit instructions. The ethanol supernatant was 
removed, and the sperm pellets were washed twice in the wash buffer and resuspended in 
100 µL of the staining solution for 1 hour at room temperature in dark. The staining 
solution contained FITC-labeled protein conjugate in distilled water. All cells were 
further washed using rinse buffer, resuspended in 250 µL and incubated for 30 minutes in 
the dark on ice for flow cytometry measurements. 
Data acquisition was performed within 30 min on a flow cytometer equipped with 
a 515-nm argon laser as a light source (FACScan; Becton Dickinson, San Jose, CA). 
10,000 cells were examined for each assay at a flow rate of 100 cells/ second. The FITC 
fluorescence was measured and data analysis was performed using FlowJo v4.4.4 
software (Tree Star Inc., Ashland, OR). 
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Figure 2-4: Experimental design of assessment of DNA oxidation using flow cytometry.   
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2.2.5 Measurement of DNA oxidation by Electrochemistry  
 Semen samples (n=5) from healthy donors were divided into 2 aliquots (sample 
and control). Each aliquot (5 X 10
6
 Sperm) was exposed to 20 min centrifugation at 1600 
rpm under 25 ºC. Controls of the same sperm concentration were incubated for 20 min at 
25ºC without centrifugation.    
2.2.5.1 Sperm DNA Extraction  
Cell lysis buffer (0.5 mL) and 60 µL of protinase K were added to both samples 
and controls and incubated overnight at 55 ºC. A 0.5 mL aliquot of chloroform: phenol 
mixture (1:1 vol./ vol.) was added and centrifuged for 5 min at 6000 rpm. The 
supernatant (aqueous layer) was collected, and 0.5 mL of chloroform was added, 
vortexed and centrifuged. The top layer was collected and mixed with 0.5 mL isopropyl 
alcohol to salt-out the white DNA pellet. The precipitated DNA was collected by 
centrifugation and the supernatant was gently decanted. Finally, the DNA was dissolved 
in 200 µL Tris-EDTA buffer and kept at 4ºC for future use.    
2.2.5.2 DNA film preparation 
 DNA films were prepared by layer-by-layer electrostatic assembly method [4]. 
The method is simply based on adsorbing thin layers from two polyelectrolytes with 
opposite charge (in this case: poly (diallyldimethylammonium chloride) (PDDA) and the 
DNA sample under investigation). Disks of ordinary basal plane pyrolitic graphite (PG) 
were abraded with 400 grit silicon carbide (SiC) paper and sonicated in water for 1 min, 
then rinsed with water and dried. The graphitic surfaces of these electrodes are then 
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oxidized in 2.5%K2Cr2O7 by scanning the potential once from 1.5V to 1.75V 
versus Ag/AgCl to form negative carboxylate groups on the surface [5]. Layers were 
formed by placing a drop of each adsorbate solution on the PG electrode for 15-20 min. 
The electrode was then rinsed with water to remove weakly adsorbed DNA and dried 
between adsorption steps. The times for steady-state adsorption, volume and 
concentration of each adsorbate solution were: (1) 15 min, 25 L of 2 mg mL-1 
poly(diallyldimethylammonium chloride) (PDDA) in 50 mM NaCl; (2) 20 min, 25 L of 
0.1-0.2 mg mL
-1 
DNA in 5 mM pH 7.1 Tris buffer and 0.50 M NaCl. Final DNA film 
architecture was denoted as the order of layer adsorption, (PDDA/DNA) 2. Alternate 
adsorption cycles were repeated until the desired number of layers was made. The 
number of layers of DNA/PDDA was optimized for the best time-sensitivity ratio. In this 
work films with 2 layers of DNA/PDDA ([DNA/PDDA]2 films) were used (Figure 2-5). 
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Figure 2-5: Electrochemical experiment design to explore the effect of sperm 
centrifugation on sperm DNA damage. Final DNA film architecture is denoted as the 
order of layer adsorption; (PDDA/DNA) 2.  
 
 
 
 
 
 
 
 35 
 
2.2.5.3 Square Wave Voltametry 
Square Wave Voltametry (SWV) was performed using CH electrochemical work 
station (CH Instruments 440A). The electrochemical cell employed an Ag/AgCl 
reference electrode, a platinum wire counter, and a film-coated PG disk as the working 
electrode. Unless otherwise noted, the SWV conditions were 4 mV step height, 25 mV 
pulse height, and 5 Hz. The electrolyte solution was 10 mM acetate buffer, pH 5.5, 
containing 50 mM NaCl and 50 µM Tris(2,2’-bipyridine)ruthenium(II), (Ru (bpy)3
2+
) as 
the reporting redox probe. 
 
2.2.6 Statistical analysis 
All values were reported as mean ± standard deviation. Difference was considered 
significant at P < 0.05 against the control group. Statistical analyses were operated using 
one-way analysis of variance (ANOVA) followed by an unpaired Student’s t-test using 
the SPSS/PC computer software (SPSS 10.0.7, SPSS Inc.). 
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2.3 Results 
2.3.1 Effect of sperm centrifugation on sperm motility and viability 
Figure 2-6 shows the effect of semen centrifugation (at 220g, 20 min) on sperm 
motility and viability. Figure 1A shows the mean values ± standard deviations of sperm 
motility for both samples and controls (i.e. without centrifugation). Sperm motility was 
significantly different between centrifuged and uncentrifuged samples (24.0 ± 12.8 vs. 
33.3 ± 14.2%) (P < 0.05; t-test). In contrast, no significant change was seen in sperm 
viability between centrifuged and uncentrifuged samples (34.2 ± 12.6 vs. 39.1 ± 9.7%, 
respectively; Fig.1B).  
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Figure 2-6: Effect of semen centrifugation on sperm motility (A) and viability (B). Sperm 
samples centrifuged 20 min at 1600 rpm; control assayed without centrifugation. Data are 
mean values ± standard deviations obtained from analysis of 16 semen samples. 
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2.3.2 Effect of semen centrifugation on total antioxidant capacity of seminal plasma 
Figure 2-7 shows the effect of semen centrifugation on the total antioxidant 
activity (TAC) in seminal plasma as measured by the CUPRAC assay. The absorbance 
measured at 450 nm is directly proportional with the TAC of semen sample.  We saw an 
insignificant difference (P > 0.05, t-test) in average absorbance (0.67 ± 0.08 vs. 0.71 ± 
0.09) at 450nm, and thus in total antioxidant capacity of seminal plasma in semen 
samples (exposed to 20 min centrifugation at 220g) and the control, Figure 2A. On the 
other hand, we observed a significant deacrease in average absorbance (0.78 ± 0.1 vs 0.62 
± 0.03) (P < 0.05; t-test) and thus in antioxidant activity in semen samples  centrifuged at 
forces between 220g and 400g under the same conditions, Figure 2B. 
2.3.3 Effect of centrifugation on sperm DNA oxidation as evaluated by flow 
cytometry 
The effect of centrifugation on sperm DNA oxidation as evaluated by flow 
cytometry is shown in Figure 2-8. The flow cytometry analysis of FITC-labeled sperm 
showed that the intensity of the FITC fluorescence increased significantly (P < 0.5, t-test) 
upon centrifugation of sperm at 220g for 20 min. The intensity of fluorescence, 
represented as mean area of FITC-fluorescence ± standard deviation, for uncentrifuged 
and centrifuged sperm were 58.5 ± 3.4 vs 210.5 ± 14.8, respectively. This result shows 
that the onset of DNA oxidative stress is significant at forces as low as 220g. 
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Figure 2-7: Effect of semen centrifugation on total antioxidant activity of seminal plasma as 
evaluated by Copper Reducing Antioxidant Capacity (CUPRAC). (A) Sperm centrifuged 20 
min at 220g; (B) sperm centrifuged 20 min at 400g. Controls assayed without centrifugation. 
The absorbance at 450 nm is proportional to the total antioxidant activity in semen. P-value < 
0.05 is considered statistically significant 
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Figure 2-8: Effect of centrifugation on sperm DNA oxidation as evaluated by flow 
cytometry. Sperm centrifuged 20 minutes at 1600 rpm; control assays without 
centrifugation. The X-axis represents the intensity of FITC fluorescence. Data are 
representative of 4 independent experiments.  
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2.3.4 Effect of centrifugation on sperm DNA oxidation as evaluated by square wave 
voltammetry 
DNA damage can also be detected through the -now standard- electrocatalytic 
oxidation of guanine bases by ruthenium tris-bipyridine as introduced by Thorp et al.[6; 
7; 8]. Damaged DNA, with open double helices or broken strands, is expected to provide 
the reporter ruthenium redox probe higher access to guanine sites, and thus would 
generate oxidation currents commensurate with the extent of DNA damage. This criterion 
(i.e. large electrocatalytic currents equivalent to large DNA damage) is used here as such 
without explanation of the fundamental concepts, which can be found in numerous 
original papers using this method [6; 7; 8].  All DNA damage measurements are carried 
out in 10 mM acetate buffer, pH 5.5 solutions containing 50 mM NaCl and 50 M 
Ru(bpy)3
2+
 as the reporter probe. All experiments are tripilcates and data points reported 
are means of 4 independent experiments.  
 
Figure 2-9 shows the voltametric response of DNA modified electrode for both 
centrifuged and uncentrifuged sperm for the desired period of time. As seen in the figure, 
an increase in the oxidation current by 17.8% (Icentrifuged sperm/Iuncentrifuged sperm = 1.178), and 
thus in sperm DNA oxidative damage, was seen in sperm samples subjected to 
centrifugation (220g) compared with the controls (without centrifugation).       
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Figure 2-9: Square wave voltametry of (PDDA/DNA) 2 films on PG electrode in pH 
5.5 buffer containing 50 µM Ru(bpy)3 
2+
. DNA samples were extracted form sperm 
exposed to 20 min centrifugation at 220g; control samples were DNA extracted form 
uncentrifuged sperm. Data are representative of 4 independent experiments.   
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2.4 Discussion  
It has been demonstrated that centrifugation has an adverse effect on sperm 
recovery rates [9]. Centrifugation < 330 g for about 15 min had insignificant effect on 
sperm motility. However a significant decrease in sperm motility was observed with 
centrifugation above 580g at the same length of time [10]. Our study shows that 
centrifugation forces as low as 220g for 20 min result in a significant decrease in sperm 
motility. We applied a longer centrifugation period (20 min) since this is an IVF protocol 
used in many andrology labs. A recent study reported by Lampiao et al. (2010) found that 
sperm centrifugation from 10 to 30 min at 400g also decreased sperm motility [11]. Our 
results are in agreement with these findings.      
In an earlier study, we reported that centrifugation of motile sperm induces the 
generation of reactive oxygen species (ROS) [12]. In sperm washing procedures, 
depriving the sperm of seminal plasma –their antioxidant reservoir-, is a main 
contributing factor behind increased levels of ROS [13]. Induced ROS, mainly hydroxyl 
radicals, were shown to affect sperm function and motility [14]. The mechanism by 
which the elevated levels of ROS decreases sperm function and motility could be via 
increasing sperm’s lipid peroxidation as well as direct oxidation of sperm DNA bases 
[14].    
The effect of centrifugation on sperm viability was assessed using the one-step 
Eosin-Nigrosin test [15]. This test is principally based the membrane permeability for the 
supravital Eosin stain. Membrane injury allows the Eosin to enter inside the spermatozoa 
and stain it. The intensity of the color is proportional with the magnitude of the damage 
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[15]. The unstained spermatozoa (white-colored under the microscope) were considered 
viable, while the stained spermatozoa, regardless the intensity of the stain color, 
considered non-viable. Our results from this experiment show that viability is not 
affected by centrifugation (at least for a 20 min centrifugation period at 220g).   
       Namik et al. (2000), in their study measured sperm viability after cryopreservation-
thawing cycles, using annexin V-Cy3 and eosin-Y staining. They noticed a significant 
variance between the percentages of sperm accepted as viable between both tests, in 
which, Eosin-Y staining test showed lower percent of live sperm compared to the annexin 
V-Cy3 test [16]. This variation is attributed to the different mechanisms through which 
these tests function. In the present study, we assessed the viability of sperm using the 
Eosin stain test that is based on the membrane permeability to Eosin. The mechanism by 
which this test categorizes the viable versus non-viable sperm could be a contributing 
factor behind the insignificant effect of centrifugation on sperm viability. Using other 
reliable viability tests may be needed for conclusive results on the effect of centrifugation 
on viability.  
As a criterion of oxidative damage exposure, we have adapted the CUPRAC 
method, developed by Apak et al. (2008), to measure the total antioxidant capacity 
(TAC) in human semen. We used this assay because the reaction is carried out at nearly 
physiological conditions. In addition, the CUPRAC method is straightforward and 
reliable [1].  
 At 220g centrifugation force, our results did not show a significant effect of 
centrifugation on TAC of semen samples compared to controls. However, we observed a 
significant decrease in semen TAC at 400g. It was reported that repeated sperm 
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centrifugation, the key step in sperm washing during processing for ART, leads to an 
excessive formation of ROS [12]. Along the same lines, a higher centrifugation force 
may induce more ROS formation [11]. Accordingly, the increased levels of ROS explain 
the decreased TAC that we observed in seminal plasma of sperm subjected to 
centrifugation at 400g.  
Our flow cytometry experiment was designed to study the effect of centrifugation 
(20 min at 220g) on sperm DNA oxidation. Sperm samples were fixed, permabilized and 
the DNA oxidation was determined via specific detection of 8-oxoguanines, biomarkers 
of DNA oxidative damage, using FITC-labeled conjugate. 
 The results from this experiment showed an increase in the baseline of sperm 
DNA oxidation in the centrifuged sperm compared to the control sample.  It instructive to 
compare our findings to results obtained by other methods. In this regard, G.D. Smith et 
al. reported that  Sperm centrifuged during washing steps with HTF show an increase in 
the DNA fragmentation using sperm chromatin dispersion assay (SCD) [17]. Our 
findings are in line with these findings, and may indicate that the increase in DNA 
damage that we observe may be the result of increase in DNA breaks.  
In live cells, including sperm, the presence of metal ions, such as ferrous and 
cupric ions, and hydrogen peroxide (H2O2) is known to produce hydroxyl radicals 
through what is termed as the Fenton reaction [18; 19]. Hydroxyl radicals are highly 
reactive oxygen species that induce lesions in DNA bases and deoxyribose sugars in 
double helix backbone, which leads to unwinding and DNA fragmentation and breaks 
[20].  
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In the electrochemical experiment, the Ru(bpy)3
2+
 redox probe reports on exposed 
guanine bases in DNA [21]. The Ru(bpy)3
2+ 
is oxidized at the electrode surface to 
Ru(bpy)3
3+
. In the presence of exposed guanine bases, the oxidized ruthenium probe is 
reduced back to Ru (II) state (eq.1), which is again reoxidized at the electrode. This 
process produce a catalytic current proportional to the number of exposed guanine bases 
[22]. The double-stranded DNA shields guanine moieties from effective contact with 
Ru(bpy)3
3+
. Guanine becomes more available after chemical damage occurs in the DNA 
this provides more exposure, and thus, access to the resulting catalyst [23].  
 
 
Ru(bpy)3
3+
  +  DNA(guanine)                              Ru(bpy)3
2+
  +  DNA(guanine
+
)     (Eq.1) 
 
 
These results show an increase in the baseline of sperm DNA damage after 
centrifugation. This is confirms our results obtained with the flow cytometry method.    
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2.5 Conclusion  
              In summary, semen centrifugation during sperm preparation for ART may  
negatively affects sperm quality, via increasing baseline of sperm DNA oxidation and 
decreasing seminal TAC and sperm motility. This might be one factor behind the 
negative reproductive outcomes such as the increased birth defects among the IVF babies 
compared to the normal babies.     
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CHAPTER III 
 
L-CARNITINE AS PROTECTIVE MEDIA FOR SPERM IN ASSISTED 
REPRODUTIVE TECHNOLOGIES 
 
Summary  
In vitro incubation and centrifugation are known to decline human sperm quality. 
In our bodies, besides its antioxidant effects, L-carnitine facilitates the transport of the 
activated fatty acids from cytosol to the mitochondrial matrix and has antioxidant effects. 
Here, we investigated the effect of L-carnitine (LC) on human sperm motility, viability 
and DNA oxidation after incubation and centrifugation, following the sperm preparation 
protocols of assisted reproduction. Normospermic semen samples (n=55) were analyzed 
according to the World Health Organization (WHO) guidelines. LC concentrations that 
are not toxic to sperm using sperm motility and viability were standardized after 2- and 4-
hour incubation at 37°C. Semen samples were also centrifuged for 20 min at 1600 rpm 
with the optimized LC concentration and analyzed for sperm motility, viability and DNA 
oxidation. Optimal improvement in sperm motility was seen at 0.5 mg/mL LC after 
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incubation and centrifugation with 5 X 10
6
 sperm/mL. Higher concentration of LC (50 
mg/mL) significantly decreased sperm motility and viability. LC did not alter the baseline 
of sperm DNA oxidation during both incubation and centrifugation. In conclusion, LC 
may enhance sperm motility following incubation and centrifugation, while it might not 
affect sperm viability and DNA oxidation.      
3.1 Introduction 
 Infertility affects one in seven couples who are trying to conceive. Male factor 
infertility is involving in up to half of all infertile couples [1; 2]. Decreased semen 
quality, a measure of the ability of semen to achieve fertilization, is a primary cause of 
male infertility. Usually, poor semen quality is characterized by low sperm motility and 
viability. Assisted reproductive techniques (ART) such as intrauterine insemination (IUI), 
in vitro fertilization (IVF) with or without intracytoplasmic sperm injection (ICSI) are the 
most successful therapeutic means for male factor infertility. 
 Sperm preparation protocols used in ART involve sperm incubation and 
centrifugation. It was reported that sperm motility and viability decrease over time after 
ejaculation [3]. Further, a rapid decline in motility was noted after incubating periods 
lasting more than 4-hours at 37ºC [4]. A recent study has found that different 
centrifugation adversely affects sperm recovery [5]. Increased centrifugation speeds (> 
500g) significantly increases the number of dead sperm [6]. Centrifugation has also been 
shown to increase the reactive oxygen species (ROS) formation in semen, which may 
affect sperm survival [7].  
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 L-Carnitine (LC) is a naturally occurring molecule, derived from the amino acid 
lysine. In cellular systems, LC serves as a facilitator for the transport of  activated fatty 
acids into the mitochondrial matrix, so that they can be broken down through β-oxidation 
to produce ATP [8]. A number of studies have examined the role of LC in reducing the 
cellular oxidative stress [9; 10; 11] (figure 3-1). Studies reported an association between 
lower levels of LC in semen and male infertility [12; 13]. Dietary supplementation with 
LC has been reported to improve sperm quality [14; 15]. Further, a positive correlation 
between free LC in human semen and sperm count and motility has been reported [16]. In 
addition, it was suggested that LC might be regarded as an index of androgenization [17]. 
In vitro as well as in vivo studies show that LC decreases the oxidative stress-induced 
DNA damage [18; 19; 20]. Furthermore, LC was reported to decrease actinomycin-D, 
hydrogen peroxide and TNF-alpha-induced DNA damage and improve the in vitro 
blastocyst development rate in mouse embryos [21].  
 The main goal of this study was first to standardize the LC doses that are not toxic 
to sperm, and examine LC effectiveness in improving sperm motility and viability, and 
decreasing sperm DNA oxidation induced by in vitro incubation and centrifugation.  
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Figure 3-1: LC function. LC facilitates the fatty acid transport into mitochondrial matrix 
and has an antioxidant effect.  
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3.2 Materials and methods 
3.2.1 Sample collection 
 This study was approved by the institutional review board of Cleveland Clinic 
Hospital. Fifty five normozoospermic men were selected and analyzed on the basis of 
normal semen analysis according to the World Health Organization (WHO, 1999) 
guidelines (section 2.2.1), and used to study the effectiveness of LC on sperm motility, 
viability and sperm DNA oxidation during incubation and centrifugation. Samples were 
collected by masturbation following a minimum of 48 to 72 hours of sexual abstinence. 
Following liquefaction at 37 ºC for 20 minutes, semen specimens were evaluated for 
volume, sperm concentration, total cell count, motility and morphology. A 5µL aliquot of 
the sample was used for evaluation of concentration and motility using a microcell slide 
chamber (Conception Technologies, San Diego, CA).  
3.2.2 Effect of various LC concentrations on sperm motility and viability  
Sixteen semen samples were examined. Each sample was divided into 6 equal 
aliquots; each contained 5 X 10
6
 sperm/ mL. Samples were supplemented with various 
concentrations of LC dissolved in phosphate buffered saline, pH 7.4 (PBS). LC 
concentrations tested were 0.1, 0.5, 1.0, 10 and 50 mg/mL. The control contained PBS in 
place of LC. Sperm motility and viability were assessed after 2 and 4-hours incubation at 
37ºC. 
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3.2.3 Measurement of sperm viability 
 Sperm viability was measured by Eosin-Nigrosin staining (see page 25, chapter 
II)  
 
3.2.4 Effect of LC on sperm motility and viability during centrifugation  
 Semen samples (n=19) were divided into two equal aliquots; each aliquot (5 x 10
6 
sperm) was supplemented with 0.5mg/mL of LC dissolved in human tubal fluid (HTF); 
control was supplemented with HTF in the place of LC. Sperm motility and viability 
were assessed after centrifugation at 1600 rpm for 20 min. 
 
3.2.5 Effect of LC on sperm motility and viability for various sperm concentrations 
during sperm incubation  
 Semen samples from 12 donors were used to examine the optimal sperm 
concentration for studying the effects of LC. Sperm concentrations used were 5, 10, 20 
and 40 X 10
6
/mL. Each aliquot was supplemented with 0.5 mg/mL LC dissolved in PBS. 
Control contained PBS in place of LC. Sperm motility and viability were measured 
immediately (time 0) and after 2h incubation at 37ºC. 
 
3.2.6 Effect of LC on sperm DNA oxidation  
 Oxidative damage to DNA was evaluated using the flow cytometric OxiDNA 
assay kit (Calbiochem, San Diego). The assay is based on utilizing a direct fluorescent 
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protein binding method targeting oxidized sites in DNA. Briefly, sperm samples were 
treated with LC concentration at 0.5 and 50 mg/mL, incubated for 2h at 37ºC, washed 
twice in PBS, resuspended in 1% paraformaldehyde at a concentration of 2-4 X 10
6
 
cell/mL, and placed on ice for 15 to 30 minutes. Sperm were again washed and 
resuspended in 70% ice-cold ethanol by centrifugation at X300g for 5 minutes as per the 
kit instructions. The ethanol supernatant was removed, and the sperm pellets were 
washed twice in wash buffer and resuspended in 100 µL of the staining solution for 1 
hour at room temperature in dark. The staining solution contained FITC-labeled protein 
conjugate and distilled water. All cells were further washed using rinse buffer, 
resuspended in 250 µL and incubated for 30 minutes in the dark on ice for flow 
cytometry measurements. Control samples without LC supplementation were subjected to 
the same assay. Negative controls were prepared without FITC staining, while the 
positive controls were prepared in the presence of 0.5 mM H2O2 and 0.25 mM FeSO4. To 
study the effect of LC on sperm DNA oxidation during centrifugation, sperm samples (5x 
10
6
 cell/mL) were treated with one volume HTF supplemented with LC concentration at 
0.5 mg/mL, centrifuged for 20 min at 1600 rpm, then submitted to the same treatment as 
described above.             
 Data acquisition was performed within 30 min on a flow cytometer equipped with 
a 515-nm argon laser as a light source (FACScan; Becton Dickinson, San Jose, CA). 
10,000 cells were examined for each assay at a flow rate of 100 cells/second. The FITC 
(log green fluorescence) was measured on FL1 channel. Data analysis was performed 
using FlowJo v4.4.4 software (Tree Star Inc., Ashland, OR). 
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3.2.7 Statistical analysis 
 All values were reported as mean ± S.D. Differences were considered significant 
at P < 0.05 against control group. Statistical analyses were operated using one-way 
analysis of variance (ANOVA) followed by an unpaired Student’s t-test using the 
SPSS/PC computer software (SPSS 10.0.7, SPSS Inc.). 
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3.3 Results 
3.3.1 Effect of LC on Sperm Motility and Viability on Incubation  
 The effect of various LC concentrations (0.1, 0.5, 1.0, 10, and 50 mg/mL) on 
sperm motility and viability was examined after 2 and 4-hour incubation periods at 37ºC 
(Figure 3-2). Sperm motility was significantly increased after LC supplementation at 0.1, 
0.5 and 1.0 mg/mL after 2 h incubation (55.0% ± 16.9%, 58.4% ± 13.9% and 52.4% ± 
19% respectively) compared with the control (39.4% ± 15%; P < 0.05) (Figure 3-2A). 
Semen samples supplemented with LC and evaluated after the 4-hours incubation period 
did not significantly increase in sperm motility compared with the control (Figure 3-2A). 
Semen supplementation with LC did not show a statistically significant increase in sperm 
viability at any concentration compared with the control at both incubation periods 
(Figure 3-2B). LC concentration of 50 mg/mL significantly reduced sperm motility and 
viability compared with the control at the two incubation periods (P < 0.05; Figure 3-2A-
B). 
3.3.2 Effect of LC on Sperm Motility and Viability during Sperm Centrifugation 
 Figure 3-3 shows the effect of LC on sperm motility and viability after sperm 
centrifugation for 20 min at 1600 rpm. Figure 3-3A shows the mean values ± standard 
deviations of sperm motility for semen samples centrifuged in presence of LC (0.5 
mg/mL) and samples centrifuged in absence of LC (control). A significant difference (P 
< 0.05) in average sperm motility (37.5 ± 16.6 vs. 24.0 ± 12.8 %) was observed between 
sperm centrifuged with LC compared to the control. The viability was comparable 
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between sperm samples treated with LC compared to those without LC treatment (38.0 ± 
12.0 vs. 34.2 ± 12.6 %, respectively) (Figure 3-3B).  
 
 Figure 3-2: Effect of various in vitro incubation with L-carnitine concentrations 
at 37ºC on sperm motility for A: 2h and B: 4 h; viability C: 2 h and D: 4h. Data are mean 
values ± standard deviations of sperm motility and viability obtained from analysis of 
sixteen different semen samples. P-values for samples and their controls were measured 
for all LC concentrations (*P-value < 0.05; **P-value <0.01); P<0.05 was considered 
statistically significant.  
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Figure 3-3: Effect of centrifugation on A: sperm motility with and without L-carnitine; 
B: sperm viability with and without L-carnitine. Sperm aliquots were centrifuged for 20 
min at 1600 rpm. All data are mean values ± standard deviations. P<0.05 are considered 
statistically significant. 
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3.3.3 Effect of LC on Sperm Motility and Viability for various Sperm 
Concentrations 
 The effect of LC at 0.5 mg/mL concentration on sperm motility and viability was 
evaluated for various sperm concentrations (5, 10, 20, and 40 million/mL) (Figure 3-4). 
Control samples without LC supplementation were subjected to the same assay 
conditions. Motility and viability of sperm were assessed immediately after 2h incubation 
at 37°C. Statistically significant increase in sperm motility was observed in semen 
samples supplemented with LC compared with the control only for a sperm concentration 
of 5 x 10
6
/mL (P < 0.05; Figure 3-4A). No increase in sperm viability was seen after 
addition of LC at all sperm concentrations tested (Figure 3-4B).          
3.3.4 Effect of LC on Sperm DNA Oxidation  
 The effect of LC on sperm DNA oxidation during incubation and centrifugation is 
shown in Figure 3-5. Flow cytometry analysis of FITC-labeled sperm showed that sperm 
treated with the LC at 0.5 and 50 mg/mL for 2h at 37 ºC did not increase the intensity of 
the FITC fluorescence, indicating an insignificant effect on the intrinsic baseline of DNA 
oxidation (Figure 3-5 A1-A2).  
 Figure 3-5B shows the effect of LC on the baseline of sperm DNA oxidation 
during centrifugation as evaluated by flow cytometry. Sperm samples centrifuged with 
LC at 0.5 mg/mL concentration did not show a significant difference in the intensity of 
FITC fluorescence, and thus in sperm DNA oxidation, compared to those without LC 
supplementation.  
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Figure 3-4: Effect of L-carnitine (0.5 mg/mL) on A: sperm motility and B: viability 
following incubation with various sperm concentration (5, 10, 20 and 40 X 10
6
/mL 
Motility and viability of sperm were assessed immediately after 2h in vitro incubation at 
37°C. The histograms are mean values ± standard deviations obtained from analysis of 
twelve different semen samples (yellow). Controls (blue) were assayed without addition 
of L-carnitine. P-values for samples and their controls were measured for all sperm 
concentrations (* P-value < 0.05); P<0.05 was considered statistically significant. 
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Figure 3-5: Effect of LC on sperm DNA oxidation during sperm incubation and 
centrifugation and evaluated by flow cytometry. A: Sperm incubated for 2h with 0.5 
mg/mL (A1) and 50 mg/mL L-carnitine concentrations (A2) at 37ºC. B: Sperm 
centrifuged in the presence of 0.5 mg/mL LC for 20 min at 1600 rpm. Sample controls 
assayed in the absence of LC in both incubation and centrifugation. Negative controls 
were analyzed without FITC staining; positive controls contained H2O2-induced sperm 
DNA oxidative damage. The X-axis represents the intensity of sperm-labeled FITC 
fluorescence. Data are representative of 4 independent experiments.  
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3.4 Discussion 
 Studies examining effects of LC on sperm quality in general have focused on the 
effects of LC in vivo. Recent findings in this context show that administration of LC 
might antagonize the oxidative, as well as the pro-inflammatory, pathways that attenuate 
sperm motility [15; 23; 24]. In the present study, we have focused on the role of LC in 
improving sperm quality in vitro. In the first series of experiments, we standardized the 
LC concentrations, utilizing semen from normozoospermic donors and established that 
0.1, 0.5 and 1.0 mg/mL concentrations were not toxic. Next, we examined sperm motility 
and viability after 2- and 4-hours of incubation.  
 To study the effect of LC on sperm motility and viability during sperm 
centrifugation, we used 0.5 mg/mL LC concentration. Sperm aliquots with and without 
LC (control) were centrifuged for 20 min at 1600 rpm. Sperm motility and viability were 
then assessed. Our results suggest that LC at the standardized concentrations was 
beneficial and improved sperm motility, in particular, after the 2h incubation period. A 
significant increase in sperm motility was observed in the centrifuged sperm 
supplemented with LC compared to the control. Similar enhancement in sperm motility 
in vitro has been reported after adding acetylcarnitine, an acetylated form of carnitine, to 
semen at 37ºC [25]. This positive effect of LC on sperm motility is due to its role in 
sperm metabolism as well as its antioxidant properties [26; 27]. LC facilitates the 
transport of long chain fatty acids across the inner membrane of mitochondria, so that 
they can be broken down through β-oxidation to produce ATP [8]; therefore, providing 
readily available energy for use by spermatozoa. Accumulation of the reactive oxygen 
species (ROS) in sperm leads to ATP depletion, lipid peroxidation and insufficient 
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axonemal phosphorylation [28]. The property of LC as a scavenger for ROS could thus 
be responsible for its positive effect on sperm motility.    
 The effect of LC on sperm viability was measured using the one-step Eosin-
Nigrosin Test [29]. This test is primarily based on the structural integrity of the 
spermatozoa plasma membrane; damage in the membrane provides an access for Eosin to 
stain the entire spermatozoa or part of it based on the size of the damage [29]. A stained 
spermatozoa is considered non-viable, while the unstained one is counted as viable.  
 LC contributes in shielding sperm membranes against harmful ROS because of its 
antioxidant activity [27]. It also decreases the availability of lipids for peroxidation via 
easing the transport of fatty acids to the mitochondrial matrix for β-oxidation [30]. 
Neuman et al. (2002) reported that dietary supplementation with LC reduces sperm lipid 
peroxidation in roosters; this may preserve sperm membranes, thereby increasing their 
viability [31]. We therefore anticipated that semen supplementation with LC would 
improve sperm viability. Contrary to our expectation, we observed that semen 
supplementation with LC showed only a slight but statistically insignificant effect in 
improving sperm viability during incubation. Similar insignificant effects were reported 
earlier by Namik et al. (2000) who studied the influence of acetyl-L-carnitine on sperm 
membrane damage after cryopreservation-thawing cycles [32]. Similarly, using in vivo 
systems, it was found that dietary supplementation with LC did not improve the 
membrane integrity of pony stallion sperm [33]. A more recent study by Yeste et al. 
(2010) showed that the addition of LC to the diet of boar males had no effect on their 
sperm viability [34]. In contrast, De Rosa et al. (2005) noted that LC administration to 
infertile human males with poor sperm motility (<50%) was effective in improving 
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membrane integrity of the ejaculated sperm.  In our in vitro study, we only added LC to 
semen samples with normal motility (>50%). A similar in vitro study, utilizing semen 
samples from infertile subjects is needed to assess LC effect on sperm viability during 
incubation and substantiate our findings.   
 Namik et al. (2000) used two assays eosin-Y staining and annexin V-Cy3 in their 
study to measure sperm viability after cryopreservation-thawing. These investigators 
observed significant discrepancy between the percentages of sperm marked as “live” 
between eosin-Y staining and annexin V-Cy3 assay. The eosin-Y staining showed lower 
percent of viable sperm compared to the annexin V-Cy3 assay [32]. These investigators 
attributed this discrepancy to the different mechanisms through which these assays 
operate. In our study, we measured sperm viability using the eosin-staining assay, which 
is based on the membrane permeability for the eosin stain. Therefore, the mechanism by 
which this assay recognizes live sperm could be a contributing factor in this insignificant 
effect of LC on sperm viability.      
 The influence of LC on sperm motility and viability of various sperm 
concentrations was also investigated (Figure 3). We supplemented different 
concentrations of sperm with LC at 0.5 mg/mL. Our results from this experiment suggest 
that LC was effective in increasing sperm motility only when utilizing sperm 
concentration of 5 x 10
6
 cell/mL. At higher sperm concentrations, the decrease in the 
ratio of the sperm number against available LC molecules may explain the lack of effect 
in improving the sperm motility. On the other hand, sperm viability did not increase 
utilizing any of the sperm concentrations. These results are in agreement with our 
experiment above. This information may be exploited in exploring and designing 
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protocols that aim to improve sperm motility in patients with low sperm count and 
especially oligozoospermic patients. 
 LC has been shown to improve resistance to oxidative stress by decreasing DNA 
damage in Ataxia telangiectasia cells [35]. Moreover, Thangasamy et al. (2009) reported 
that LC significantly reduces DNA damage in lymphocytes of aged rats [18]. We also 
recently demonstrated the effectiveness of LC in reducing H2O2-induced DNA damage 
and improvement of in vitro blastocyst development rate in mouse embryos [21]. In the 
present study, we examined if LC had similar effects on human sperm DNA in vitro. We 
incubated the sperm samples with the standardized LC concentration 0.5 mg/mL, at 37ºC 
for 2h. We did not see the decrease in the extent of the sperm DNA oxidation (Figure 3-
5-A1). Similarly, we did not see a significant effect of LC on the baseline of sperm DNA 
oxidation after centrifugation compared with control samples (i.e. centrifugation without 
LC) (Figure 3-5-B). 
 Studies in vitro show that semen supplementation with an antioxidant does not 
affect sperm DNA integrity. In fact, Donnelly et al. (1999) showed that neither addition 
of ascorbate nor addition of α-tocopherol to sperm preparation medium affected DNA 
integrity of sperm. However, both antioxidants provided protection against the H2O2-
induced DNA damage in sperm [36]. Similar reports showed that addition of vitamin E to 
cryopreservation medium did not alter the post-thaw DNA fragmentation of sperm [37]. 
These results are in line with our observations, which don’t show a significant effect of 
LC as an antioxidant LC in reducing DNA oxidative damage in sperm. 
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 Very low concentrations of LC have been reported in azoospermic men compared 
with normospermic control [38]. Further, lower concentrations of LC were noted in 
oligoasthenozoospermic males, and LC supplementation was shown to improve semen 
quality in these people [39]. One explanation for the undetectable effect of LC on sperm 
DNA oxidation may be the fact that we used only semen samples from normozoospermic 
subjects in our study. Furthermore, contrary to majority of reported studies [21; 23; 35; 
36], we measured the effect of LC on the baseline levels of oxidative DNA damage in 
sperm without any induction of oxidative damage as in other studies this might be 
another likely reason for the lack of significant effect of LC on sperm DNA oxidation. 
Another reason for lack of improvement in DNA oxidation may be the fact that 
mammalian sperm DNA is highly compacted (six-fold more highly condensed) compared 
to DNA in somatic cells [40]. Also, the majority of antioxidants in somatic cells are 
present within their cytoplasm, while in sperm, a significant amount of the antioxidants 
are present in seminal plasma outside the sperm because spermatozoa lose most of its 
cytoplasm during maturation [41]. Therefore, the differences in the DNA packaging and 
the distribution of antioxidants between spermatozoa and somatic cells might introduce 
variations in outcomes when measuring the effect of in vitro supplementation of 
antioxidants on DNA oxidation.     
 Given that LC is a substantial antioxidant [27; 42], the role of antioxidant therapy 
in improving male fertility could be a double-edged sword with unfavorable effects if the 
safety threshold dose is exceeded [42]. For example, extreme levels of the known 
antioxidant L-ascorbic acid are thought to be associated with a decline in fertility [43], 
even though it is the principal antioxidant in seminal plasma of fertile males [44]. Further 
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research is needed before the role for antioxidants in the treatment of male infertility is 
established [45]. The in vitro studies on human sperm by Donnelly et al. (1999) showed 
that higher concentrations of L-ascorbic acid (> 20 µM) negatively affect sperm motility 
in both normozoospermic and asthenozoospermic samples. Our findings are in agreement 
with this concept, and we have shown that sperm quality in vitro is lower at high 
concentrations of LC. 
 It has been shown that cell treatment with high concentrations of antioxidants in 
vitro increases the levels of 8-oxoguanine moieties on DNA, a biomarker for DNA 
oxidative damage [46]. Increasing DNA oxidative damage may lead to apoptosis and cell 
death [47; 48]. We therefore examined if high LC concentration decreased in vitro sperm 
quality by inducing sperm DNA oxidation. We measured the 8-oxoguanine moieties in 
the sperm DNA after incubating the sperm with 50 mg/mL LC using flow cytometry. Our 
results suggest that this might not be the likely mechanism by which the high LC level 
affects negatively sperm quality in vitro (Figure 3-5-A2). Again, the fact that we used 
samples from normozoospermic subjects may contribute to the absence of significant 
effects in our work.  
 In conclusion, LC enhances sperm motility following in vitro incubation and 
centrifugation, while it might not significantly affect sperm viability and DNA oxidation 
baseline of sperm. Our results provide a solid ground to explore and design protocols to 
test potentially beneficial effect of LC supplementation for sperm prepared for ART.   
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CHAPTER IV 
 
NITRIC OXIDE IN HUMAN MALE REPRODUCTION 
 
 
  Summary 
In this chapter, we provide a literature review of the role of nitric oxide (NO), one 
of the main reactive oxygen species, in human male reproduction. The goal of this review 
is to enrich our understanding of the molecular basis of the function of NO in human 
spermatozoa.  In the beginning of this chapter, we discuss nitric oxide synthesis and 
mechanisms of action and function in cellular systems. Then, we provide a 
comprehensive literature review of the role of NO in human spermatozoa physiology and 
function, as well as its contribution as a marker in male infertility diagnosis. In addition, 
we provide an in-depth review of NO antagonistic effects on spermatozoa function and 
physiology. Moreover, we review the methods that are commonly used to measure NO in 
semen. The collective information from this literature survey points to the fact that some 
level of NO is vital for human sperm function and physiology and mainly for the motility 
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of spermatozoa. However, increased levels of NO are considered detrimental to 
spermatozoa and contribute to male infertility.   
 
4.1 Nitric oxide, function and synthesis 
 
Nitric oxide (NO) is a diatomic free radical. It is similar to oxygen in its 
maximum solubility in water. NO is also a non-polar molecule and able to diffuse easily 
through cellular membranes [1]. One of the most distinctive chemical features of NO is 
that it is paramagnetic, does not have a tendency to make dimers  at the standard 
conditions [2].      
Currently, it is one of the extensively studied species in biomedicine because of 
its various functions in biological systems. It has been referred to as the endothelium-
derived relaxing factor (EDRF) because it causes vasodilation via a cascade that leads to 
vascular smooth muscle relaxation [3; 4; 5]. In addition, nitric oxide prevents platelets 
aggregation [6], acts as a neurotransmitter [7; 8], and mediates macrophage bactericidal 
activity.   
Reports have shown that NO has a major contribution in human reproduction. It is 
recognized as a key molecule in controlling hypothalamic-pituitary-gonadal axis [1]; it 
activates the release of  luteinizing hormone-releasing hormone (LHRH), which triggers 
the pituitary gland to release the gonadotropins via activating nNOS in the pituitary [9]. 
In the gonad, it has a central role in inducing ovulation in human’s female and in causing 
luteolysis [9]. NO has also a significant contribution in human’s sexual behavior; in 
males, it induces the erection via generating cyclic guanosine monophosphate (cGMP) in 
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corpora cavernosa [10]. In females, it relaxes vaginal smooth muscle and induces vaginal 
secretions [9].  
    
 
 
 
 
 
 
 
 
 
Figure 4-1: Synthesis of nitric oxide.  
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NO is synthesized by a family of enzymes called nitric oxide synthases (NOSs) 
from the oxidation of arginine. NO is released after a two-step catalytic cycle along with 
citrulline as a byproduct. O2 and NADPH, the reduced form of nicotinamide adenine 
dinucleotide phosphate, are required in this reaction (figure 4-1). Flavin adenine 
dinucleotide (FAD), flavin mononucleotide (FMN), and tetrahydrobiopterin, are also 
needed for the NOS reaction [11]. In tissues, NO has a very short half-life (3 to 10 
seconds) because it reacts with oxygen (O2) and and converts into nitrite and nitrate.  It 
also reacts with superoxide ion (O2-
.
)  and thiol sites to yield peroxynitrite and 
nitrosothiols respectively. 
 
4.2 NO synthases  
 Three isoenzymes of NO synthase have been identified. Endothelium NOS 
(eNOS), primarily present in endothelium, neuronal NOS (nNOS), primarily present in 
neural tissue, and inducible NOS (iNOS), can be expressed in various cells such as 
macrophages, monocytes, neutrophils and hepatocytes [11; 12]. 
 The isoforms eNOS and nNOS are constitutive, synthesized usually at a steady 
rate in spite of physiologic need, and Ca
2+
-calmodulin-dependent enzymes [11; 12] . 
iNOS is a Ca
2+
-independent enzyme;  it has specific inducers (e.g. inflammatory 
cytokines, tumor necrosis factor, bacterial endotoxins) which vary by cell type. These 
inducers increase iNOS synthesis, which can result in a large amount of NO being 
formed [13; 14; 15].  
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4.3 NO and smooth muscle contraction:  
In endothelial cells, NO is synthesized by eNOS and diffuses into vascular smooth 
muscle (VSM), and activates the cytosolic –soluble- guanylate cyclase (sGC), which 
increases the production of cGMP, and consequently, protein kinase G (PKG). PKG then 
phosphorylates myosin light-chain kinase and leaves it inactive, thereby lowering smooth 
muscle contraction.  
 
4.4 Nitric oxide mechanisms of action mediated by peroxynitrite 
In biological systems, peroxynitrite, which results from the combination of NO 
with superoxide ion (O2-
.
),
 
is a double-edged sword anion. It has both beneficial and 
detrimental actions. These actions, endogenous and exogenous, are mostly due to 
oxidation and nitration reactions with other biomolecules, mainly proteins, lipids and 
nucleic acids (Figure 4-2) [16]. The effects of peroxynitrite could be both direct and 
indirect. For example, peroxynitrite produces small concentrations of secondary NO 
when reacting with other biomolecules and promotes vasodilation, inhibition of platelet 
aggregation and hypotension [17].       
 
1. Role in bactericidal activity 
Normally, iNOS activity in macrophages is not high. In response to infection, by 
the effect of interferon-alpha and bacterial lipopolysaccharides (LPS), its synthesis 
increases resulting in higher NO production. NO combines with O2-
. 
 and form 
peroxynitrite (ONOO
-
), which, among other reaction pathways, breaks down in the 
presence of hydrogen ion into HO
.
, a highly bactericidal radical (scheme 1).                
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Scheme 1: Formation of hydroxyl radical from nitric oxide.  
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2. Effects on proteins and enzymes   
Various proteins in humans and other biological systems are targets for 
peroxynitrite attacks. Oxidation and nitration of proteins may down-regulate the positive 
feedback cycles of injury and decreases the ability of the cell to fight against free radical 
damage. This will lead to antioxidant depletion, oxidative stress, and consequently, cell 
necrosis or apoptosis. Such cases are more likely when peroxynitrite attacks antioxidant 
enzymes such as the superoxide dismutase and glutathione reductase, as well as, other 
species of antioxidant defense mechanisms like glutathione and cysteine [16; 18-22]. 
Inhibition of cytosolic as well as membrane proteins and enzymes because of 
peroxynitrite attack leads to impairment of cell function, and subsequently disease onset 
(Table 4-1).   
 
3. Lipid oxidation and nitration by peroxynitrite 
The decomposition of peroxynitrite, in the presence of hydrogen ion, to form •OH 
and •NO2 may initiate lipid peroxidation when it occurs in hydrophobic phases [16; 23].  
The reaction results in Lipid peroxidation products such as malondialdehyde, 
hydroperoxide and conjugated diene [23], as well as in the nitro, nitrito-, nitrosoperoxo- 
and nitrated lipid oxidation products. Low-density lipoprotein (LDL) is also a target for 
peroxynitrite insult. LDL oxidation by peroxynitrite leads to the formation of F2-
isoprostanes [16; 24], a family of prostaglandin-like compounds formed via non-
enzymatic lipid peroxidation.  Fatty acids nitration may secondarily inhibit protein 
function through thiol modifications [25]. Conversely, nitrated lipids can have anti-
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inflammatory functions via peroxisome proliferator-activated receptor gamma (PPAR-
γ)-dependent and independent pathways [16; 26].     
 
4. Effect on DNA   
DNA is also another target for peroxynitrite and its derived radicals. They can 
cause DNA base modification; for example, 8-oxoguanine and 8-nitroguanine are main 
products of purine oxidation [27]. Furthermore, it can activates Ca
2+
-Mg
2+
- 
endnonucleases [16]. In addition, peroxynitrite can oxidize deoxyribose sugar and lead to 
double and single strand breaks [16; 28]. Such DNA injury may lead to genotoxic 
damage, which may develop into pathological disorders. Peroxynitrite may also induce 
secondary DNA repair and activate the suicidal pathway including poly ADP-ribose 
polymerase activation (PARP-activation), and consequently cell necrosis (Figure 4-2) 
[29].           
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Table 4-1: Examples of cytosolic and membrane enzymes and proteins affected by 
peroxynitrite (adapted from Casaba Szabo et al., 2007). 
 
 
Enzyme or protein  Mechanism of action  Consequences and related 
health disorders  
Ref. 
Glyceraldehyde-3-
phosphate 
dehydrogenase   
Oxidation of cysteine  
residues  
Impairment of cellular 
function  
 
[30] 
Tyrosine hydroxylase  Nitration of tyrosine 
residues  
 
Impaired the production of 
dopamine in the 
dopaminergic neurons (e.g. 
in Parkinson disease)  
 
[31] 
Creatine kinase  Oxidation of cysteine  
residues 
Impairment of myocytes 
function, which may leads to 
myocardial infarction or 
chronic heart failure. 
[16; 
32] 
Calcium pumps: 
including 
sarco/edoplasmic 
reticulaum Ca
2+
-
ATPase (SERCA) 
 
Tyrosine nitration and 
cysteine oxidation 
Impairment of cellular 
calcium handling and 
cellular ionic balance, which 
is linked with heart failure.  
[33; 
34] 
Epidermal growth 
factor receptor (EGF) 
Dimerization, 
nitration and 
oxidation  
Cellular signaling 
impairment including a 
possible pathway leading to 
insulin resistance  
[16; 
35] 
Prostacyclin synthase  Oxidation and 
nitration  
Prostaglandin formation 
inhibition.  
[36] 
    
Alpha-synuclein and 
microtubule related tau 
protein modification in 
CNS   
Nitration and 
oxidation  
Initiation pathogenesis of 
alpha-synuclein aggregates 
[16; 
37] 
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Figure 4-2: nitric oxide actions mediated by peroxynitrite.   
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5. Effect on NOS cofactors 
 
Peroxynitrite can impair enzymatic cofactors directly or indirectly via free 
radical-dependent mechanisms. It can oxidizes tetrahydrobiopterin (BH4) (Figure 4-3), a 
cofactor of NOS enzyme that serves as an electron relay for timed redox reactions used in 
oxygen activation. The oxidation of BH4 leads to the inactive form quinonoid 5,6-
dihydrobiopterin [38] which is subsequently converted to 7, 8-dihydrobiopterin. This 
oxidation affects negatively the function of NOS, and thus NO production [16]. Milstien 
and Katusic (1999) have suggested that abnormally low concentrations of BH4 may 
promote a cycle of its own destruction arbitrated by NOS-dependent formation of 
peroxynitrite; such mechanism might have a contribution in vascular endothelial 
dysfunction stimulated by oxidative stress [38].  
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Figure 4-3: Chemical structure of tetrahydrobiopterin (A), and 7, 8-dihydrobiopterin (B). 
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4.5 Nitric oxide and male infertility 
Studies have shown that NO has a major contribution in male reproduction [39- 
44]. Higher levels of nitric oxide were recognized in the semen of infertile men compared 
to  fertile [42]. It was found that NO generation is very important in gamete interaction 
and fertilization route [45]. Xu et al. (2008) studied the relationship between nitric oxide 
synthase and nitric oxide with varicocele-based infertility; they found that NO mediates 
the decrease in semen quality induced by varicocele [46]. A recent study reported that the 
missense Glu298Asp polymorphism of eNOS gene is present at a higher frequency in 
infertile asthenozoospermic  subjects [47].  
  Supplementation of asthenozoospermic infertile men ejaculates with 
Ginsenoside R (e) improves human’s male fertility by increasing sperm motility [48]. 
The mechanism by which this occurs may involve NOS stimulation and enhanced NO 
synthesis [48]. Huang et al. (2006) studied the correlation between NO levels and sperm 
morphology; they found that low concentrations of NO are associated with defects in 
sperm morphology [49]. A very recent study showed that increased levels of NO is linked 
with a decrease in sperm function in asthenospermia, normospermia and 
leukocytospermia, whereas, lower levels of NO may contribute in the etiology of 
oligospermia [50].   
 
4.6 Nitric oxide synthases in human spermatozoa 
NOSs are ubiquitous, present in almost all tissues of the human body [51]. NOS 
activity has been verified in human testes, seminal vesicles, and prostates [52]. These 
findings imply a possible function of NO in spermatogenesis and the maturation of 
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sperm. It has been recognized that nitric oxide synthase (NOS) is present in human 
spermatozoa and NO production at endogenous levels is very important for adequate 
sperm function [48; 51; 53-55]. Lewis et al. (1996) reported that human spermatozoa 
express eNOS as well as nNOS [53]. At a later date (1998), Moria et al. confirmed that 
human spermatozoa express eNOS. The same group, using immunohistochemistry, 
detected the presence of eNOS in sperm and showed that the majority of sperm display 
postacrosomal and equatorial eNOS staining (head and midpiece). In 2000, Francavilla et 
al. concluded that constitutive NOS (eNOS and nNOS) plays a role in the capability of 
human sperm to fuse with oocyte in the zona pellucida (ZP), a glycoprotein membrane 
that surrounds the plasma membrane of an oocyte. They showed that inhibited 
constitutive NOS activity using N
G
-nitro-l-arginine methyl ester (L-NAME) significantly 
decreased the oocyte fusion without affecting the ZP binding [56]. Newly published 
study showed that increased NOS activity is present in mature sperm compared to 
immature [57].  
NOS activity was also studied in seminal plasma. Both calcium-dependent NOS 
activity as well as calcium-independent NOS activity were detected in human seminal 
plasma [58]. There was no association between NOS activity in seminal plasma and 
sperm motility and concentration [58]. Later, another study supported these findings by 
showing that seminal plasma nitrite does not correlate with sperm count and rapid-
forward motility [59]. In addition, positive sperm culture did not increase the 
concentration of nitrite in seminal plasma [59].  
On a related front, mRNA transcripts of eNOS and nNOS have been detected in 
semen samples, and they have a clinical significance in the diagnosis of fertilization [60]. 
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For example, eNOS and nNOS transcripts were present in low motile sperm samples, 
while they are undetectable in the high motile ones [60]. 
 
4.7 Nitric oxide and sperm motility 
Flagellum beating is very important to sperm motion; defects in sperm motility 
leads to infertility and ectopic pregnancy [61]. Several studies showed that NO 
production at endogenous levels is very important for adequate sperm motion [48; 51; 53-
55]. Insulin, a central hormone in regulating carbohydrate metabolism in the human 
body, and leptin, an adipose-derived hormone, significantly increased in vitro motility 
and nitric oxide production in sperm [15] (Figure 4-4). Ankri et al. (2009) proposed that 
exposure of human spermatozoa to visible light may increase NO formation, which 
enhances the motility of sperm, and thus the rate of fertilization. According to the same 
group, this effect may be attributable to increase of light absorbance by the NOS 
coenzymes flavin and heme. Lately, an in vitro study observed that adding L-arginine to 
asthenospermic patient’s semen samples increases NO production and sperm motility. 
This effect happens only in the presence of an active anion transport system [62].     
It was also reported that sperm recovery is also altered upon using dissimilar 
methods to prepare sperm in vitro. Ding et al. (2002) used two different methods, Percoll 
and IxaPrep, to prepare human sperm in vitro and they found that the IxaPrep method 
provides a better recovery rate of sperm. They concluded that the better sperm quality by 
the IxaPrep method may be the result of decreased levels of NO generated, because 
increased levels of nitric oxide affects negatively the quality of the sperm [63].   
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Figure 4-4: various compounds and factors increase sperm motility may be by increasing 
NO production.  
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4.8 Nitric oxide mechanisms of action in human sperm 
Miraglia et al. (2010) showed that NO stimulates human spermatozoa motility by 
activation of soluble guanylate cyclase (sGC), subsequent production of cyclic guanosine 
monophosphate (cGMP) and activation of cGMP-dependent protein kinases 
(cGMP/protein kinase G signaling pathway) [64]. An earlier study suggested that NO 
induces acrosomal reaction in human spermatozoa via stimulating sGC, cGMP, and PKG 
activation, and extracellular Ca
2+
 is required in this activation [65].  
Alternatively, by a mechanism that does not require sGC activation; L. Lefievre et 
al. (2007) demonstrated that many proteins (signaling, regulatory, kinases, receptors, 
transport, structural and others) in human spermatozoa are possible targets for S-
nitrosylation, a dynamic mechanism analogous to phosphorylation in which a nitrosyl 
group is added to a protein (25). In general, S-nitrosylation by nitric oxide is very 
important reaction in biological systems; it refers usually to the conversion of thiol 
groups, involving cysteine residues in proteins, to S-nitrosothiols, such examples are 
shown above (Table 4-1) (26, 27). 
A subsequent study reported that NO has a key function in the gamete interaction 
and fertilization within human female’s tract. It regulates the mobilization of stored Ca2+ 
ions in human spermatozoa via protein S-nitrosylation, which ultimately lead to the 
regulation of flagellar beating. This action is synergistic with the action of progesterone 
(Figure 4-5) [66]. The pre-treatment of sperm with NO increased significantly the effect 
of progesterone on intracellular free calcium ions, possibly by binding on a membrane 
surface receptor, which activates Ca
2+
 influx using a plasma membrane channels [45]. 
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Increasing intracellular Ca
2+
 induces mobilization of stored calcium via a Ca
2+
-induced 
Ca
2+
 release process (CICR). 
On another front, reports have shown an association between apoptosis 
mechanisms in sperm and NO synthesis. For example, activation of apoptosis signaling in 
human spermatozoa is negatively correlated with NO production [57]. 
 
4.9 Role of nitric oxide in human sperm capacitation and acrosomal reaction 
Sperm capacitation is an ultimate biochemical event that occurs typically in the 
female’s reproductive tract after ejaculation. It is required for the spermatozoa to be 
competent for oocyte penetration. A number of studies reported that NO is important for 
human sperm capacitation [67; 68; 69]. It was indicated that NO is formed by 
capacitating human spermatozoa [70]. NO may act as a messenger via modulating the 
cAMP/protein tyrosine phosphorylation pathway involved in spermatozoa capacitation 
[70]. Herrero et.al. (2001) emphasized that capacitation is part of an oxidation process 
that involves NO. They demonstrated that the nitration of tyrosine in sperm proteins by 
NO takes place in capacitated human spermatozoa [71]. Later study found that NO 
regulates the phosphorylation of threonine-Glutamine-Tyrosine motif in human 
spermatozoa proteins of 80 and 105 kDa through capacitation [72]. Others have shown 
the effect of Ginsenoside Re, a bioactive component from ginseng, on sperm capacitation 
and acrosomal reaction occurs through NO-dependent cGMP/ protein kinase G signaling 
pathway [73]. De Lamirande and Lamothe (2009) showed a close interaction between 
NO and superoxide ion (O2-
•
) during human sperm capacitation is needed for acquisition 
of fertility [69]. Inhibition of NO generation as well as other ROS by semenogelin, the 
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predominant protein in human semen, blocks sperm capicitation [74].  On the other hand, 
nitric oxide at low concentrations increased human sperm capacitation through  
enhancement of sperm-zona pillucida (ZP) binding capacity [75].     
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Figure 4-5: Synergistic effect of NO and progesterone (modified from Linda et al., 
2009). 
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4.10 Adverse effects of NO on sperm physiology and function 
It has been shown that NO is vital for appropriate sperm function, while 
overproduction of this reactive free radical has also pathologic implications, particularly 
on the motility of sperm [55]. Induced oxidative stress to human sperm in vitro using 
high doses of H2O2 showed a significant increase in NO levels and a significant decrease 
in sperm motility [55; 76]. Rosselli et al. (1995) found that higher levels of nitric oxide 
decrease the quality of sperm in vitro [40]. Later study on varicocele suggested that nitric 
oxide synthase released within the dilated spermatic vein establishes a high oxidative 
stress state as a result of increased production of NO. Formation of peroxynitrite from the 
reaction of NO with superoxide ion also affects sperm function in varicocele patients 
[77]. On the other hand, no significant relationship was found between NO 
concentrations and the severity of athenozoospermia, oligoospermia, and abnormal sperm 
morphology in these people [78].    
 Treatment of purified spermatozoa with NO-doses from NO-donors such as S-
nitroso-N-acetylpenicillamine and sodium nitroprusside decreased both sperm motility 
and viability [40; 42; 79]. The nitric oxide generator, SIN-1 (3-morpholinosydnonimine 
hydrochloride), was used as a spermicidal agent [80]. Adding the calcium ionophore 
A23187, an activator of both eNOS and nNOS, to human sperm medium increased 
significantly the production of NO [54] and, as a result, decreased sperm motility. Others 
showed that the overproduction of NO in the genital tract of infertile human subjects 
decreases the integrity of sperm DNA [81]. A later study demonstrated that TNF-alpha 
and IL-6, two cytokines involved in inflammation, decrease sperm motility possibly via 
inducing NO formation [82].   
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In contrast, melatonin (N-acetyl-5-methoxytryptamine), a hormone secreted by 
pineal gland and responsible for circadian rhythm, is able to scavenge directly and 
indirectly NO in human sperm. Accordingly, it was concluded that supplementation of 
sperm medium with melatonin might be able to counteract the adverse effects of NO on 
sperm [83].  
 
4.11 Measurement of NO in semen  
The most common method used to measure NO in human semen is nitrite 
colorimetric assay, also known as the Griess assay. In this assay, NO is assessed 
indirectly via measuring its breakdown product nitrite (NO2
-
), formed by spontaneous 
oxidation of NO [84]. The detection limit for this assay is 1 μM nitrite [84].  Sulfanilic 
acid first reacts with NO2
-
, in the semen sample to produce an intermediate diazonium, 
which then reacts with N-(1-naphthyl) ethylenediamine and form a stable azo dye, which 
absorbs light at 540nm [85]. To accurately measure all nitric oxide produced in the 
sample, some reports first convert all nitrate to nitrite using nitrate reductase enzyme, 
before using the Griess assay [85].  
 
Chemiluminescence is another method commonly used to determine NO in 
semen. The detection is based on NO reaction with ozone (O3), which leads to red light 
emission (Scheme 4-2). Photons detected from this reaction, using a photomultiplier tube 
are transformed to an electrical signal that is proportional to the amount of measured NO 
[63].   
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Scheme 4-2: reaction of NO with ozone.  
 
 
 
 
Others have used other techniques to measure NO production at cellular level 
such as electron paramagnetic resonance (EPR) spectroscopy and spin trapping [70]. 
Such techniques are not commonly used in the andrology laboratories because they are 
more complicated and not readily available to common andrology laboratories [86; 87]. 
In the following chapter, we have standardized a direct method to measure nitric oxide in 
human spermatozoa using flow cytometry. 
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4.12 Conclusion  
Nitric oxide synthases, mainly the constitutive isoforms, are present in human 
spermatozoa. Physiologic levels of NO are vital for human sperm function and 
physiology, mainly for adequate flagellar beating and progressive motion. The effects of 
NO on human spermatozoa could be direct or indirect (mediated by peroxynitrite and/or 
its derivatives). Decreased levels of NO impair the function of spermatozoa. Likewise, 
excessive levels of NO contribute to oxidative stress and are detrimental to sperm quality. 
Although the evidence cited in this chapter shows that NO is very important for human 
sperm quality such as adequate sperm motility, many of its roles and mechanisms of 
action in sperm are yet to be fully unveiled.      
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CHAPTER V 
 
A NEW METHOD FOR MEASUREMENT OF NITRIC OXIDE PRODUCTION 
IN HUMAN SPERMATOZOA USING FLOW CYTOMETRY 
 
Summary   
         
Studies showed that nitric oxide (NO) has a major contribution in male 
reproduction. However, many of NO’s mechanisms of action in sperm remain unclear; 
one important reason is that methods for direct NO measurement at the level single cells 
and/or collections of cells are not straightforward. Here we demonstrated a method to 
measure intracellular NO in human sperm by means of flow cytometry using NO-specific 
probe 4,5-diaminofluorescein-2-diacetate (DAF-2DA). Motile sperm are freshly prepared 
using a modified direct swim-up procedure. Both sperm and DAF-2DA concentrations 
are standardized. Sperm samples incubated with L-nitro-arginine methyl ester (L-
NAME), a Nitric Oxide Synthase (NOS) inhibitor, showed lower fluorescence in a dose-
dependent manner. Sperm samples supplemented with Diethylamine NONOate (DEA 
NONOate), a nitric oxide donor, showed higher fluorescence compared to the control. At 
last, we used this method to measure the effect of L-carnitine, a motility stimulant as we 
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have showed in the third chapter, on NO production in human spermatozoa. We found 
that LC may increases sperm motility via increasing the production of NO.     
 
 
5.1 Introduction   
 
Nitric oxide (NO) is one of the most studied molecules in biomedicine because of 
its various physiological functions. As we have reported in the previous chapter, it has 
been referred to as an endothelium-derived relaxing factor because it causes vasodilation 
via relaxing vascular smooth muscle [1; 2; 3]. In addition, it prevents platelets 
aggregation [4], acts as a neurotransmitter [5; 6], and mediates macrophage bactericidal 
activity [7].  
Reports have shown that NO has a significant involvement in male reproduction 
[8; 9]. Various studies showed that endogenous NO is very important for sperm motion 
[10- 14].  NO generation was found to be crucial in gamete interaction and fertilization 
route [15]. A number of studies reported that NO is involved in human sperm 
capacitation [16; 17; 18]. In contrast, others have shown that higher levels of nitric oxide 
were observed in infertile men compared to control groups [19].  
Although the evidence above points to the fact that NO is very important for 
human sperm physiology and function, its exact mechanisms of action in sperm are yet to 
be fully understood. The majority of measurement of NO in sperm relied on nitrite 
determinations using colorimetric assays. This may not relay an accurate picture on NO 
concentration and its fluctuations in spermatozoa. Methods that have the potential to 
follow NO concentration under varying conditions within cells are of particular 
importance to investigate the mechanisms of actions of NO in sperm function.  
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Analysis by flow cytometry has entered many andrology laboratories and has 
been used to evaluate sperm count and viability [20], to detect antisperm antibody [21; 
22] and to study the chromatin structure of sperm [23]. The considerable advantage of 
flow cytometry is that millions of cells can be analyzed in seconds, providing a 
statistically more precise assessment of the level of analyte under consideration. Here, we 
demonstrated a method to detect the intracellular NO in human sperm using the NO-
specific probe 4,5-diaminofluorescein-2-diacetate (DAF-2DA). The specific detection of 
NO and the sensitivity of fluorescence are coupled to the high throughput capability of 
flow cytometry; this provides a specific, sensitive, and fast method of monitor NO 
concentration in spermatozoa under varying experimental conditions.  
 
5.2 Materials and methods 
Sample collection 
       Our study was approved by the institutional review board of Cleveland Clinic 
Hospital. Normospermic men were selected and analyzed based on normal semen 
analysis according to the World Health Organization (WHO) (1999) guidelines (section 
2.2.1). Fresh semen samples were used to standardize the measurement of intracellular 
NO in sperm using DAF-2DA by means of flow cytometry.   
Samples were collected by masturbation following a minimum of 48 to 72 hours 
of sexual abstinence. Following liquefaction at 37 ºC for 20 minutes, semen specimens 
were evaluated for volume, sperm concentration, total cell count, motility and 
morphology. A total amount of 5µL of the sample was used for evaluation of 
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concentration and motility using a microcell slide chamber (Conception Technologies, 
San Diego, CA). 
 
Preparation of motile sperm samples 
Motile sperm were retrieved from semen samples using direct swim-up technique. 
This procedure was adapted from the one described by World Health Organization (1999) 
(section 2.2.1). Briefly, spermatozoa are selected based on the ability to swim out of 
seminal plasma into the human tubal fluid (HTF). We use only untreated, fresh semen in 
this process. 0.8 ml of homogenized semen was pipetted carefully under 1 ml of HTF 
placed in a 15 ml conical centrifuge tube while avoiding the mixing between the semen 
and the supplemented medium. Afterward, the tube was left at 90º angle for 1 hr at 37ºC. 
The uppermost (~ 0.6 – 0.8 µL) medium containing only the highly motile sperm is 
transferred to another test tube, and centrifuged for 4 min at 1600 rpm. Then, the top 
layer was discarded, and the sperm in the bottom resuspended in 0.5 mL HTF. The 
resulting motile sperm are washed and their concentration adjusted as needed. 
 
DAF-2DA preparation 
DAF-2DA was dissolved in dimethyl sulfoxide (DMSO) because it has a very low 
solubility in water. Although DMSO is a very suitable solvent for DAF-2DA, it is 
considered toxic to human sperm when added at higher concentrations [24]. Therefore, in 
our experimental design, we added DAF-2DA/DMSO solution to sperm medium at a 
concentration of ≤ 5% (v/v).  We did not see a statistical difference in sperm viability 
after adding DMSO of ≤ 5% (v/v) compared to sperm without DMSO (Figure 6-5). We 
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run our experiments in the dark conditions in order to avoid the exposure of DAF-2DA to 
the light, because fluorescein can be easily photobleached, a photochemical destruction 
of  the fluorophore [25] . 
 
Measurement of DAF-2T fluorescence at various sperm concentrations 
 
The concentration of washed motile sperm is adjusted with HTF to within 0.5- 8.0 
x 10
6
/ mL range. The samples (n=6) are then supplemented with 20 µM of DAF-2DA, 
incubated for 90 min at 37 ºC in dark, and analyzed with flow cytometry. Identical 
samples without addition of DAF-2DA are used as controls.  
 
Measurement of DAF-2T fluorescence at various DAF-2DA concentrations                          
Samples (n=6) of 2 x 10
6
/mL sperm concentration are incubated with various 
concentrations (0.5 nM, 5 µM, 50 µM, 0.5 mM and 1 mM) of DAF-2DA for 90 min at 37 
ºC in dark. After incubation, the fluorescence of DAF-2T was measured using flow 
cytometry along with control samples. 
 
 
Measurement of sperm viability 
 
Sperm viability was measured by the Eosin-Nigrosin staining procedure (see page 
25, chapter II) 
 
NO measurement in sperm after NOS inhibition 
 
Sperm samples (n=8) at 2 x 10
6
/mL concentration are incubated at 37ºC with 
various concentrations (100, 400 and 800 µM) of the NOS inhibitor N
w –nitro -L-arginine 
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methyl ester (L-NAME) for 120 min in the dark. 15 min after the addition of L-NAME, 
DAF-2DA is added to the samples to a final concentration of 20 µM. The fluorescence of 
DAF-2T is measured immediately after incubation using flow cytometry. Samples 
without incubation with L-NAME are taken as controls for this series of experiments. 
  
NO measurement in the presence of an exogenous NO donor. 
 
Sperm samples (n=6) at 2 x 10
6
/mL concentration were incubated at 37ºC with 
various concentrations (10, 100, 300, 500 and 800 µM) of the NO donor 2-(N,N-
diethylamino)-diazenolate-2-oxide, sodium salt (DEA-NONOate) for 45 min in dark. 
DAF-2DA at 20 µM is added to the samples 45 min prior to the addition of the NO 
donor. The fluorescence of DAF-2T was measured immediately after incubation using 
flow cytometry. Samples in absence of NONOate are taken as controls. 
 
 
Flow cytometry 
Flow cytometry data acquisition is completed within 10-15 min from sample 
preparation. The flow cytometer (FACScan; Becton Dickinson, San Jose, CA) is 
equipped with a 515-nm argon laser as a light source. Samples are adjusted to have 
20,000 cells examined for each assay at a flow rate of 100 cells/second. Data analysis is 
performed using FlowJo v4.4.4 software (Tree Star Inc., Ashland, OR). 
In our flow cytometry data, we used 20,000 count from the 2 x 10
6
/mL total 
sperm in each sample to obtain consistent measurements. The threshold value of the 
forward scatter (FSC) was set < 40 FSC to exclude small cells, cell fragments, and debris 
from the analyzed sperm. The sperm window was established after running multiple 
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unstained sperm samples (instrumental control) submitted to swim up and followed by 
washing with HTF.   
 
 
Statistical analysis 
 All values were recorded as mean ± S.D. Differences between samples and their 
control were considered significant at P < 0.05. Statistical analyses were performed by 
one-way analysis of variance (ANOVA) and an unpaired Student’s t-test using the 
SPSS/PC computer software (SPSS 10.0.7, SPSS Inc.) 
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5.3 Results and discussion 
 
The work we presented here is a modification of what Strijdom et al. (2004) and 
S. du Plessis et al. (2006) have described [26; 27]. The fluorescent NO-indicators 
diaminofluoresceins (DAFs) were first designed and synthesized by Kojima et al (1998) 
[25]. DAF-2DA, a non-fluorescent dye, is able to cross the membrane of live cells and is 
hydrolyzed to 4,5-diaminofluorescein (DAF-2) by intracellular esterases [28]. DAF-2 
reacts rapidly with NO (in the presence of O2; the reaction is actually with an NO
+
 
equivalent likely from a nitrogen oxide derivative of NO) to form the fluorescent dye 
triazolofluorescein (DAF-2T) (Figure 5-1). DAF-2T fluoresces at 515 nm upon excitation 
at 495 nm. Because of the specificity of the reaction of DAF-2 with NO, the intensity of 
the fluorescence is proportional to the amount of intracellular NO generated. 
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Figure 5-1: Schematic representation of fluorometric NO measurement procedure for 
human spermatozoa using the DAF-2DA precursor. 
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Effect of sperm concentrations on DAF-2T fluorescence at 20 µM DAF-2DA 
To determine the optimum sperm concentration of samples used in our flow 
cytometry measurements, we monitored DAF-2T fluorescence as a function sperm 
concentration for a set concentration of the dye DAF-2DA at 20 µM (Figure 5-2). No 
significant difference (P > 0.05; t-test) in average fluorescence is seen between sample 
with sperm concentrations 0.5, 1.0 and 2.0 x 10
6
/mL. On the other hand, a significant 
difference (P < 0.05; t-test) in average fluorescence is observed at higher concentrations 
(4 and 8 x 10
6
/mL). Unstained control samples (i.e. 0.0 µM DAF-2DA) exhibit very 
negligible fluorescence. 
Our experiments indicate that concentrations in the range of 0.5-2.0 x 10
6
/mL
 
could all be used for a set DAF-2DA concentration of 20 µM. Sample with higher sperm 
concentrations such as 4x or 8x10
6
/mL
 
showed lower fluorescence, likely a direct result 
of a lower ratio of DAF-2DA molecules per sperm cell. 
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Figure 5-2: Observed fluorescence as a function of sperm concentration with 20 
µM dye concentration. The values reported are averages ± standard deviations; n=6. The 
control is the unstained sample.  
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Effect of DAF-2DA concentrations on observed fluorescence  
 
Figure 5-3 shows flow cytometry histograms of DAF-2DT fluorescence (A) as 
well as the mean areas for these histograms (B) at various concentrations of DAF-2DA 
(0.5 nM -1 mM). All DAF-2DA concentrations used show a statistical increase (P < 0.05; 
t-test) in fluorescence compared to unstained control samples (without DAF-2DA). 
Sperm samples incubated with 50 µM of DAF-2DA show the highest intensity of DAF-
2T fluorescence, while the lowest fluorescence is seen for 0.5 nM dye concentration. The 
intensity of the fluorescence decreased at higher doses (above 0.5 mM) of DAF-2DA 
used.    
          Our results showed a statistically significant increase in fluorescence even at a low 
concentration of DAF-2DA of ~ 0.5 nM compared to the control sample (without DAF-
2DA). Because concentrations of 0.5 mM and 1 mM of DAF-2DA exhibited lower 
fluorescence compared to 50 M, we examined if sperm viability is compromised at 
these higher concentrations. Indeed, we find that the millimolar range of dye 
concentration significantly affects sperm viability, which explains the observed decrease 
in fluorescence (Figure 5-4).  
 
 
 
 
 
 
 
 126 
 
 
Figure 5-3: (A) Flow cytometry histograms of DAF-2T fluorescence as a function of 
concentrations of the DAF-2DA dye (0.5nM, 5µM, 50µM, 0.5mM, 1mM); (B) Mean 
areas of DAF-2T fluorescence at the various DAF-2DA doses; data are means (for n=6) ± 
standard deviations; the control is the unstained sample (i.e. no DAF-2DA). Sperm 
concentration used in the sample was 2 x 10
6
/mL with 20,000 cells acquired in flow 
cytometry.   
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Figure 5-4: Effect of various DAF-2DA concentrations on sperm viability as evaluated 
by the Eosin-Nigrosin test. The evaluation of sperm viability performed immediately 
after the flow cytometry measurements. Data are means (n=6) ± standard deviations. 
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Dynamic NO sensitivity of DAF-2DA in the presence of NOS inhibitor and an NO donor. 
To determine the dynamic sensitivity of this fluorometric method to sudden 
variations of intracellular NO concentration in spermatozoa, we monitored fluorescence 
changes in response to an NO donor as well as in the presence of a NOS-inhibitor. 
a. Effect of the NOS inhibitor L-NAME on observed fluorescence   
Figure 5-5 shows the effect of various concentrations (100, 400, and 800 µM) of 
L-NAME on the observed DAF-2T fluorescence. Data represented are mean areas of 
fluorescence ± standard deviations. The figure shows a significant decrease (P < 0.05) in 
the intensity of fluorescence of DAF-2T in the presence of L-NAME in a dose dependent 
manner. The fluorescence decrease of DAF-2T did not significantly change for L-NAME 
concentrations between 100 and 400 µM (P > 0.05; t-test).       
b. DAF-2T fluorescence in response to varying concentration of the NO donor 
The specificity of DAF-2DA to measure NO and to respond to increases of 
intracellular NO concentration was validated using incubation with DEA-NONOate, a 
known NO donor. 
Figure 5-6 shows the effect of various concentrations of DEA-NONOate, the NO 
releasing compound, on observed fluorescence in human sperm. We observed significant 
increase in fluorescence in samples with 100 µM NO donor concentration while the 
change was not significant with 10 µM. Also, the mean area of DAF-2T fluorescence did 
not increase significantly above the level measured with 100 µM NONOate for 
concentrations above 300 µM. 
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Figure 5-5: DAF-2T flow cytometry fluorescence in human sperm as a function of L-
NAME concentration. Data are means (n=10) ± standard deviation. 
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Figure 5-6: DAF-2T flow cytometry fluorescence in human sperm as a function of 
NONOate concentration. Data are means (n=6) ± standard deviations. 
 
 
 
 
 
 
 
 
 
 
 131 
 
Our results show that the fluorescence of DAF-2T increases after adding the NO 
donor, indicating that the method follows dynamic increases of intracellular NO. 
However, the method shows that the fluorescence did not increase significantly beyond 
the level seen for 100 M of the NO donor. It is known that concentrations of NONOates 
(in the range of 0.3- 1.0 mM) affect sperm motility [17]. In addition to sperm motility, we 
suspected that sperm viability might be behind the sluggish increase (for 300 M) and 
then decrease of DAF-2 fluorescence (for 500-800 M). To confirm this, we measured 
the viability of sperm immediately after the flow cytometry analysis (Figure 5-7). As 
expected, the figure shows a significant decrease in sperm viability after 100 µM in NO 
donor. This is not a surprise since literature reports established that NO donors can have 
both a protective role (at low concentration) but can also induce cell death in a variety of 
cell types at high concentrations [29; 30]. The cytotoxic effects of NO are mainly due to 
higher oxides that derive from NO and that are more reactive. Peroxynitrite is one of 
them and has many reactivity facets under physiologic conditions which contribute to cell 
dysfunction, including the disruption of the cell’s ability to sustain healthy levels of 
endogenous NO, as well as other vital functions.  
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Figure 5-7: Effect of varying concentration of NONOate on sperm viability as evaluated 
by the Eosin-Nigrosin test. The viability test is conducted immediately after the flow 
cytometry analysis. Sperm concentration was 2 x 10
6
/mL. Data are means (n=6) ± 
standard deviations. 
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5.4 Conclusion  
Collectively, these findings show that measurement of intracellular nitric oxide in 
human sperm can be performed using the DAF-2DA fluorometric method coupled to 
flow cytometry. The method has now been standardized for human spermatozoa and will 
be of assistance to elucidate the NO mechanisms of action in human sperm as well as its 
role in maintaining sperm quality or in inducing cytotoxicity. 
 
5.5 Effect of L-Carnitine (LC) on NO production in human spermatozoa assessed by 
the DAF-2DA fluorometric method coupled with flow cytometry 
In this section, we measured the effect of L-carnitine (LC) on NO production in 
human sperm using the method that we have standardized as described in the previous 
section of this chapter. As we have seen in chapter III, supplementation of sperm with LC 
at 0.5 mg/mL increased sperm motility. On the other hand, as we described previously, 
nitric oxide has been implicated for adequate sperm function including motility. Our goal 
here is to test whether LC supplementation causes the levels of endogenous NO to 
increase in sperm. This may be a mechanism by which LC stimulates sperm motility. 
 
Methodology and experimental design 
 
 
Highly motile sperm were prepared using direct swim up and adjusted to 2 x 
10
6
/mL concentration with HTF. After that, Semen Samples (n=4) were supplemented 
with 0.1 mg/mL LC, followed by addition of DAF-2DA at 20µM concentration. Samples 
were then incubated for 90 min at 37°C in the dark. After incubation, the fluorescence of 
DAF-2T formed was measured immediately using flow cytometry as described in above.  
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Results and discussion  
In chapter 2, we have shown that 0.5 mg/mL LC concentration is beneficial to 
sperm at 5 million/mL. Here we supplemented the sperm with LC at 0.1 mg/mL because 
we treated lower sperm number (2 million/mL). Figure 6-7 shows the effect of 0.1 
mg/mL LC on DAF-2T fluorescence in human spermatozoa. The figure shows an 
increase in DAF-2T fluorescence, and thus an increase in the intracellular NO produced 
in the sperm supplemented with LC. Control samples assayed without LC 
supplementation do not show any significant increase in fluorescence. Data in the figure 
are representative of four independent experiments. As reported in chapter 4, NOS in all 
of its isoforms is present in human spermatozoa. NO has a major role in the physiology 
and function of the spermatozoa [10; 31]. A number of studies showed that NO is very 
important for adequate motility of human spermatozoa [12; 17; 32]. Our results from the 
fluorometric determination of intracellular NO production in spermatozoa upon 
incubation with LC show a causal relationship between LC supplementation and NO 
production. Whether the LC-induced NO production is direct or via an indirect pathway 
cannot be concluded and awaits further investigation. For now, the evidence shows that 
LC induces intracellular NO production, and this may explain the enhanced motility of 
spermatozoa incubated with L-Carnitine.  
  
 
 
 
 
 
 
 135 
 
 
 
 
Figure 5-8: Effect of LC on DAF-2T fluorescence in human spermatozoa. Sperm (2 x 
10
6
/mL) incubated 90 min with 20 µM DAF-2DA in the presence of 0.1 mg/mL LC (a), 
and without LC (b). The control histogram is for sperm population without DAF-2DA, 
and without LC. Data are representative of four independent experiments.    
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